tafamidis meglumine 20 MG Oral Capsule [Vyndaqel]
RxNorm concept 2168548, branded drug (sbd). Prescribable name: Vyndaqel 20 MG Oral Capsule.
- RxCUI
- 2168548
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2168548 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Vyndaqel 20 MG (equivalent to tafamidis 12.2 MG) Oral Tablet; Vyndaqel 20 MG Oral Capsule
Related concepts
- tafamidis meglumine 20 MG (SCDC, consists of)
- tafamidis meglumine 20 MG [Vyndaqel] (SBDC, consists of)
- Oral Capsule (DF, has dose form)
- Vyndaqel (BN, has ingredient)
- tafamidis meglumine 20 MG Oral Capsule (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2168548 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2168548 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2168548. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.